Tofacitinib in Scleritis: A Case Series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib in Scleritis: A Case Series

Published:2022-09-20 Issue: Volume: Page:1-7
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Pyare Richa¹,Dutta Majumder Parthopratim¹,Shah Mauli¹,Kaushik Viswanathan²,Agarwal Mamta¹,Biswas Jyotirmay¹³

Affiliation:

1. Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India

2. Department of Rheumatology, Apollo Hospital, Chennai, India

3. Department of Ocular Pathology, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India

Funder

associated with the work featured in this

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2022.2113805

Reference21 articles.

1. Clinical features and visual outcomes of Japanese patients with scleritis

3. Scleritis and episcleritis.

4. Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital

5. Severity of Scleritis and Episcleritis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for necrotizing scleritis in rheumatoid arthritis patients;Expert Review of Ophthalmology;2024-07-23

2. Long-Term Outcome of Tofacitinib Treatment for Systemic Autoimmune Disease-Associated Refractory Scleritis;Ocular Immunology and Inflammation;2024-05-31

3. Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series;Ocular Immunology and Inflammation;2024-03-05

4. Branch retinal vein occlusion in a case of recalcitrant diffuse anterior scleritis treated with tofacitinib;Journal of Ophthalmic Inflammation and Infection;2023-09-27

5. Necrotizing Scleritis: A Review;Ocular Immunology and Inflammation;2023-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3